1 not yet recruiting, 1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow P-Gemox: new trials by email Literature Review of P-Gemox trials Research Report on P-Gemox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL. P-GEMD, P-Gemox - NK-T-Cell Lymphoma, Extranodal | Phase 3 | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 60 | 2025-05-01 | 2025-05-01 |
| Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma Sintilimab+Pegaspargase, P-GemOx, GELAD - Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Phase 2 | Recruiting | Fudan University | 210 | 2024-03-04 | 2026-04-09 |
Lymphoma, Extranodal NK-T-Cell (1)
Fudan University (1) · The First Affiliated Hospital with Nanjing Medical University (1)
China (1)
Jinhua Liang (1) · Rong Tao, MD (1) · Wei Xu (1)